Mario Schlosser, a director at Oscar Health, Inc. (NYSE:OSCR), filed a Form 4 on August 31, 2026, disclosing the exercise of stock options and the sale of Class A common stock on August 27 and August 28, 2026.

Key Highlights

  • August 27 sale: Schlosser disposed of 600,000 shares of Class A common stock at a weighted average price of $30.34, with individual transactions ranging from $29.98 to $30.73.
  • August 28 sale: Schlosser disposed of 150,000 shares of Class A common stock at a weighted average price of $30.79, with individual transactions ranging from $30.59 to $30.89.
  • Option exercises: Schlosser exercised fully vested stock options with an exercise price of $9.75 per share, covering 600,000 shares on August 27 and 150,000 shares on August 28, both expiring December 16, 2029.
  • Direct ownership after transactions: Following both days of activity, Schlosser directly held 480,866 shares of Class A common stock, including shares to be issued upon vesting of restricted stock units.
  • Indirect holdings: Schlosser also holds indirect interests in Class A common stock through three trusts: 283,333 shares via the Siena Pizzo-Schlosser Dynasty Trust, 283,333 shares via the Noah Pizzo-Schlosser Dynasty Trust, and 538,333 shares via the Pizzo-Schlosser Family Dynasty Trust.

Transaction Details from Oscar Health Director's Form 4 Filing

According to the filing, the transactions on August 27, 2026 involved the exercise of a stock option covering 600,000 shares of Class B common stock at $9.75 per share, followed by the conversion of those Class B shares into 600,000 Class A shares, and then the sale of those 600,000 Class A shares at a weighted average price of $30.34. The filing notes that sales on that date occurred across multiple transactions at prices ranging from $29.98 to $30.73 per share.

On August 28, 2026, the same sequence was repeated for 150,000 shares: a stock option exercise at $9.75 per share, conversion of Class B to Class A shares, and a sale of 150,000 Class A shares at a weighted average price of $30.79, with individual prices ranging from $30.59 to $30.89. The filing states that the stock options involved are fully vested and exercisable, and that they expire on December 16, 2029.

The filing also notes that Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-for-one basis, and will mandatorily convert seven years from the date of the prospectus used in connection with Oscar Health's initial public offering, subject to conditions set out in the issuer's certificate of incorporation. Oscar Health is a health insurance company that offers individual and small group coverage and operates through a technology-driven platform. The disclaimer in the filing states that Schlosser disclaims beneficial ownership over shares held by the three dynasty trusts "except to the extent of his pecuniary interest therein, if any."

What Was Disclosed

Mario Schlosser, a director of Oscar Health, reported the exercise of fully vested stock options and the subsequent sale of Class A common stock on August 27 and August 28, 2026, with direct beneficial ownership of 480,866 Class A shares following the transactions, plus indirect holdings through three family trusts.